跳至主要内容
临床试验/NCT01945801
NCT01945801已完成4 期

The Effect of Sodium-Restricted Diet and Diuretic in the Severe Sleep Apnea: a Randomized Controlled Trial - DESALT Study

Hospital de Clinicas de Porto Alegre1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2013年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
54
试验地点
1
主要终点
Apnea-Hypopnea Index

研究概览

简要总结

This study evaluates the intervention of the 1) sodium-restricted diet, or 2) diuretic, or 3) placebo pill in the treatment of obstructive sleep apnea in adults.

详细描述

Men with apnea-hypopnea index greater than 30/hour will be included and randomly assigned into three groups: sodium-restricted diet, or diuretic, or control. The intervention will last one week. The diuretic group will receive combined spironolactone 100mg plus furosemide 20mg daily. The diet group will receive a regimen with a maximum intake of three grams of sodium per day. The control group will receive a placebo pill and will maintain all eating habits.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Men in the age range from 18 to 60 years
  • Full-night in-laboratory polysomnography with apnea-hypopnea index > 30/h in the last three months
  • Body mass index < 35 kg/m2
  • Informed consent

排除标准

  • Already having started any treatment for sleep apnea, including use of continuous positive airway pressure
  • NYHA heart failure, any class
  • Predominantly central apnea
  • Peripheral venous or lymphatic insufficiency
  • Any chronic renal disease
  • Use of diuretics and substances with action in the central or peripheral nervous system such as benzodiazepines, hypnotics, anticonvulsants, antidepressants, appetite suppressants, amphetamines, antiparkinson agents, muscle relaxants, bronchodilators
  • Stroke within 6 months or with incapacitating sequelae
  • Any physical, mental or social condition impairing the ability to participate in the trial

研究组 & 干预措施

Lasilactone

Active Comparator

Dosage form: One capsule taking in the morning Dosage: furosemide, 20mg, and spironolactone, 100 mg. Frequency and duration: One capsule daily for 7 days.

干预措施: Lasilactone (Drug)

placebo pill

Placebo Comparator

One capsule taking in the morning. Frequency and duration: One capsule daily for 7 days.

干预措施: Placebo (Drug)

Sodium-Restricted Diet

Active Comparator

The diet group will receive a regimen with a prescribed intake of three grams of sodium per day

干预措施: Sodium-Restricted Diet (Other)

结局指标

主要结局

Apnea-Hypopnea Index

时间窗: One week

Number of apneas/hour

次要结局

  • Somnolence scale (Epworth) and ventilatory parameters(One week)
  • Dosages of urinary 24h(One week)
  • Glycolipid profile(One week)
  • Aldosterone Renin Level Activity(One week)
  • Inflammatory marker(One week)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Sodium-Restricted Diet and Diuretic in the Treatment... | 临床试验